Adverum Biotechnologies (ADVM) Misses Q3 EPS by 1c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• BofA expects mid to outperform small stocks in the H2
• Rank One Computing (ROC) Reiterated at Buy by Benchmark Post ZTC Acquisition